Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 1/20 | 0.39 |
| ▸ | ITGAV | P06756 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | CACNA1H | O95180 | 4/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.34 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.34 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.34 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.34 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.34 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.34 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.34 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23817079 | 1.00 | ITGB3 (0.39) | ITGB3ITGAVALDH1A1SIGMAR1L3MBTL1 | |
| SCHEMBL15362287 | 0.84 | ITGB3 (0.41) | ITGB3ITGAVALDH1A1SIGMAR1L3MBTL1 | |
| SCHEMBL19016242 | 0.84 | ITGB3 (0.41) | ITGB3ITGAVALDH1A1SIGMAR1L3MBTL1 | |
| SCHEMBL19016233 | 0.82 | ALDH1A1 (0.44) | ITGB3ITGAVALDH1A1SIGMAR1L3MBTL1 | |
| SCHEMBL10036356 | 0.82 | ITGB3 (0.41) | ITGB3ITGAVALDH1A1SIGMAR1L3MBTL1 | |
| SCHEMBL16602341 | 0.81 | ITGB3 (0.46) | ITGB3ITGAVALDH1A1SIGMAR1L3MBTL1 | |
| SCHEMBL24589222 | 0.80 | SMN1; SMN2 (0.42) | ALDH1A1SMN1; SMN2HDAC3HDAC4HDAC1 | |
| SCHEMBL24588472 | 0.80 | SMN1; SMN2 (0.42) | ALDH1A1SMN1; SMN2HDAC3HDAC4HDAC1 | |
| SCHEMBL25955621 | 0.77 | DRD4 (0.38) | ALDH1A1CACNA1HKCNH2 | |
| SCHEMBL22354583 | 0.77 | ALDH1A1 (0.33) | ALDH1A1L3MBTL1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11046743-B2 | Selective glucagon receptor agonists comprising a chelating moiety for imaging purposes | ANTAROS MEDICAL AB (SE) | 2021-06-29 | — | — | US | disclosed |
| EP-3389697-B1 | SELECTIVE GLUCAGON RECEPTOR AGONISTS COMPRISING A CHELATING MOIETY FOR IMAGING PURPOSES | ANTAROS MEDICAL AB (SE) | 2020-12-16 | — | — | EP | disclosed |
| US-20200262885-A1 | SELECTIVE GLUCAGON RECEPTOR AGONISTS COMPRISING A CHELATING MOIETY FOR IMAGING PURPOSES | ANTAROS MEDICAL AB (SE) | 2020-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200262885-A1 | SELECTIVE GLUCAGON RECEPTOR AGONISTS COMPRISING A CHELATING MOIETY FOR IMAGING PURPOSES | GLP1R, GCGR, GIPR | ITGB3 2215/4885ITGAV 2336/4885ALDH1A1 4763/4885 |
| US-11046743-B2 | Selective glucagon receptor agonists comprising a chelating moiety for imaging purposes | GLP1R, GCGR, GIPR | ITGB3 2215/4885ITGAV 2336/4885ALDH1A1 4763/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.